Administered By

• Duke Clinical Research Institute

Awarded By

• Takeda Pharmaceutical Company Limited 

Contributors

• Johnson, F. Reed Principal Investigator
• Leiman, David Asher Co Investigator

Start/End

• November 13, 2020 - September 30, 2022